In insulin-autoantibody-positive children from the general population, antibody affinity identifies those at high and low risk
- PMID: 16010521
- DOI: 10.1007/s00125-005-1864-6
In insulin-autoantibody-positive children from the general population, antibody affinity identifies those at high and low risk
Abstract
Aims/hypothesis: Insulin autoantibodies (IAA) precede and predict the onset of type 1 diabetes, but not all children with IAA develop the disease. In affected families, IAA affinity can identify IAA-positive children who are more likely to progress to diabetes. The purpose of this study was to determine whether affinity is a useful marker to stratify type 1 diabetes risk in IAA-positive children from the general population.
Methods: IAA affinity was determined by competitive binding to 125I-insulin with increasing concentrations of cold insulin and with cold proinsulin in sera from 46 IAA-positive children identified in the Karlsburg Type 1 Diabetes Risk Study of a Normal Schoolchild Population in north-eastern Germany.
Results: IAA affinity ranged between 5 x 10(6) and 1.2 x 10(11) l/mol. IAA affinity was higher in 24 children who developed multiple islet autoantibodies or diabetes (median 3.5 x 10(9) l/mol; interquartile range [IQR] 2.1x10(9) to 2.1 x 10(10) l/mol) than in 22 children who did not develop multiple islet autoantibodies or diabetes (median 1.3 x 10(8) l/mol; IQR 3.8 x 10(7) to 7.2 x 10(8) l/mol; p<0.0001). Using a threshold of > or = 10(9) l/mol, 22 of the 24 children who developed multiple islet autoantibodies or diabetes were correctly identified by high-affinity IAA and 18 of 22 who did not develop multiple islet autoantibodies or diabetes were correctly identified by low-affinity IAA. IAA affinity was significantly higher in samples with proinsulin reactive IAA (p<0.0001).
Conclusions/interpretation: IAA affinity measurement provides robust identification of IAA associated with high diabetes risk.
Similar articles
-
Mature high-affinity immune responses to (pro)insulin anticipate the autoimmune cascade that leads to type 1 diabetes.J Clin Invest. 2004 Aug;114(4):589-97. doi: 10.1172/JCI21307. J Clin Invest. 2004. PMID: 15314696 Free PMC article.
-
Islet autoantibody phenotypes and incidence in children at increased risk for type 1 diabetes.Diabetologia. 2015 Oct;58(10):2317-23. doi: 10.1007/s00125-015-3672-y. Epub 2015 Jul 3. Diabetologia. 2015. PMID: 26138334
-
A simplified method to assess affinity of insulin autoantibodies.Clin Immunol. 2010 Dec;137(3):415-21. doi: 10.1016/j.clim.2010.09.002. Clin Immunol. 2010. PMID: 20920845
-
Developments in the prediction of type 1 diabetes mellitus, with special reference to insulin autoantibodies.Diabetes Metab Res Rev. 2005 Sep-Oct;21(5):395-415. doi: 10.1002/dmrr.554. Diabetes Metab Res Rev. 2005. PMID: 15895384 Review.
-
The molecular specificity of insulin autoantibodies.Diabetes Metab Res Rev. 2000 Sep-Oct;16(5):338-53. doi: 10.1002/1520-7560(2000)9999:9999<::aid-dmrr145>3.0.co;2-l. Diabetes Metab Res Rev. 2000. PMID: 11025558 Review.
Cited by
-
The immunology of type 1 diabetes.Nat Rev Immunol. 2024 Jun;24(6):435-451. doi: 10.1038/s41577-023-00985-4. Epub 2024 Feb 2. Nat Rev Immunol. 2024. PMID: 38308004 Free PMC article. Review.
-
Understanding Islet Autoantibodies in Prediction of Type 1 Diabetes.J Endocr Soc. 2024 Jan 2;8(1):bvad160. doi: 10.1210/jendso/bvad160. eCollection 2023 Dec 1. J Endocr Soc. 2024. PMID: 38169963 Free PMC article. Review.
-
Effective assay technologies fit for large-scale population screening of type 1 diabetes.Front Clin Diabetes Healthc. 2023 Jan 23;3:1034698. doi: 10.3389/fcdhc.2022.1034698. eCollection 2022. Front Clin Diabetes Healthc. 2023. PMID: 36992730 Free PMC article. Review.
-
Islet Autoantibody Standardization Program: interlaboratory comparison of insulin autoantibody assay performance in 2018 and 2020 workshops.Diabetologia. 2023 May;66(5):897-912. doi: 10.1007/s00125-023-05877-9. Epub 2023 Feb 10. Diabetologia. 2023. PMID: 36759347 Free PMC article.
-
A High-throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19.J Vis Exp. 2022 Jul 5;(185):10.3791/63787. doi: 10.3791/63787. J Vis Exp. 2022. PMID: 35876559 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical